AAAAAA

   
Results: 1-18 |
Results: 18
Role of fibroblast growth factor receptor signaling in prostate cancer cell survival
Authors: Ozen, M Giri, D Ropiquet, F Mansukhani, A Ittmann, M
Citation: M. Ozen et al., Role of fibroblast growth factor receptor signaling in prostate cancer cell survival, J NAT CANC, 93(23), 2001, pp. 1783-1790
Alternative splicing of fibroblast growth factor receptors in human prostate cancer
Authors: Kwabi-Addo, B Ropiquet, F Giri, D Ittmann, M
Citation: B. Kwabi-addo et al., Alternative splicing of fibroblast growth factor receptors in human prostate cancer, PROSTATE, 46(2), 2001, pp. 163-172
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
Authors: Kwabi-Addo, B Giri, D Schmidt, K Podsypanina, K Parsons, R Greenberg, N Ittmann, M
Citation: B. Kwabi-addo et al., Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression, P NAS US, 98(20), 2001, pp. 11563-11568
Secreted caveolin-1 stimulates cell survival/clonal growth and contributesto metastasis in androgen-insensitive prostate cancer
Authors: Tahir, SA Yang, G Ebara, S Timme, TL Satoh, T Li, LK Goltsov, A Ittmann, M Morrisett, JD Thompson, TC
Citation: Sa. Tahir et al., Secreted caveolin-1 stimulates cell survival/clonal growth and contributesto metastasis in androgen-insensitive prostate cancer, CANCER RES, 61(10), 2001, pp. 3882-3885
Interleukin-6 is an autocrine growth factor in human prostate cancer
Authors: Giri, D Ozen, M Ittmann, M
Citation: D. Giri et al., Interleukin-6 is an autocrine growth factor in human prostate cancer, AM J PATH, 159(6), 2001, pp. 2159-2165
Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia
Authors: Giri, D Ittmann, M
Citation: D. Giri et M. Ittmann, Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia, AM J PATH, 159(1), 2001, pp. 139-147
Elevated caveolin-1 levels in African-American versus white-American prostate cancer
Authors: Yang, G Addai, J Ittmann, M Wheeler, TM Thompson, TC
Citation: G. Yang et al., Elevated caveolin-1 levels in African-American versus white-American prostate cancer, CLIN CANC R, 6(9), 2000, pp. 3430-3433
Absence of PTEN/MMAC1 pseudogene in mice
Authors: Kwabi-Addo, B Thompson, TC Ittmann, M
Citation: B. Kwabi-addo et al., Absence of PTEN/MMAC1 pseudogene in mice, DNA CELL B, 19(5), 2000, pp. 301-305
FGF-10 is expressed at low levels in the human prostate
Authors: Ropiquet, F Giri, D Kwabi-Addo, B Schmidt, K Ittmann, M
Citation: F. Ropiquet et al., FGF-10 is expressed at low levels in the human prostate, PROSTATE, 44(4), 2000, pp. 334-338
Androgen receptor mutations in prostate cancer
Authors: Marcelli, M Ittmann, M Mariani, S Sutherland, R Nigam, R Murthy, L Zhao, YL DiConcini, D Puxeddu, E Esen, A Eastham, J Weigel, NL Lamb, DJ
Citation: M. Marcelli et al., Androgen receptor mutations in prostate cancer, CANCER RES, 60(4), 2000, pp. 944-949
Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer
Authors: Ropiquet, F Giri, D Kwabi-Addo, B Mansukhani, A Ittmann, M
Citation: F. Ropiquet et al., Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer, CANCER RES, 60(15), 2000, pp. 4245-4250
Interleukin-1 alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia
Authors: Giri, D Ittmann, M
Citation: D. Giri et M. Ittmann, Interleukin-1 alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia, AM J PATH, 157(1), 2000, pp. 249-255
Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer
Authors: Giri, D Ropiquet, F Ittmann, M
Citation: D. Giri et al., Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer, CLIN CANC R, 5(5), 1999, pp. 1063-1071
Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men
Authors: Nastiuk, KL Mansukhani, M Terry, MB Kularatne, P Rubin, MA Melamed, J Gammon, MD Ittmann, M Krolewski, JJ
Citation: Kl. Nastiuk et al., Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men, PROSTATE, 40(3), 1999, pp. 172-177
Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma
Authors: Giri, D Ittmann, M
Citation: D. Giri et M. Ittmann, Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma, HUMAN PATH, 30(4), 1999, pp. 419-424
FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation
Authors: Ropiquet, F Giri, D Lamb, DJ Ittmann, M
Citation: F. Ropiquet et al., FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation, J UROL, 162(2), 1999, pp. 595-599
FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells
Authors: Giri, D Ropiquet, F Ittmann, M
Citation: D. Giri et al., FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells, J CELL PHYS, 180(1), 1999, pp. 53-60
Mitogenic activation of human prostate-derived fibromuscular stromal cellsby bradykinin
Authors: Walden, PD Lefkowitz, GK Ittmann, M Lepor, H Monaco, ME
Citation: Pd. Walden et al., Mitogenic activation of human prostate-derived fibromuscular stromal cellsby bradykinin, BR J PHARM, 127(1), 1999, pp. 220-226
Risultati: 1-18 |